These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18981395)

  • 1. Effects of peritoneal dialysis solutions low in GDPs on peritonitis and exit-site infection rates.
    Furkert J; Zeier M; Schwenger V
    Perit Dial Int; 2008; 28(6):637-40. PubMed ID: 18981395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (Balance).
    Lee HY; Park HC; Seo BJ; Do JY; Yun SR; Song HY; Kim YH; Kim YL; Kim DJ; Kim YS; Ahn C; Kim MJ; Shin SK
    Perit Dial Int; 2005; 25(3):248-55. PubMed ID: 15981773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.
    Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW;
    Perit Dial Int; 2015 Dec; 35(7):712-21. PubMed ID: 26224790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between types of dressing following catheter insertion and early exit-site infection in peritoneal dialysis.
    Figueiredo AE; de Mattos C; Saraiva C; Olandoski M; Barretti P; Pecoits Filho R; de Moraes TP;
    J Clin Nurs; 2017 Nov; 26(21-22):3658-3663. PubMed ID: 28122398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies to universally improve peritonitis rates, including use of dialysis solutions with low glucose degradation products.
    Diaz-Buxo JA; Himmele R
    Adv Perit Dial; 2010; 26():37-40. PubMed ID: 21348377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
    Bernardini J; Bender F; Florio T; Sloand J; Palmmontalbano L; Fried L; Piraino B
    J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a silver device in preventing catheter-related infections in peritoneal dialysis patients: silver ring prophylaxis at the catheter exit study.
    Pommer W; Brauner M; Westphale HJ; Brunkhorst R; Krämer R; Bundschu D; Höffken B; Steinhauer HB; Schümann E; Lüttgen FM; Schillinger-Pokorny E; Schaefer F; Wende R; Offner G; Näther S; Osten B; Zimmering M; Ehrich JH; Kehn M; Mansmann U; Grosse-Siestrup C
    Am J Kidney Dis; 1998 Nov; 32(5):752-60. PubMed ID: 9820444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical Honey in the Management of Pediatric Peritoneal Dialysis Exit Sites.
    Forbes TA; Shaw L; Quinlan C
    Perit Dial Int; 2016 11-12; 36(6):684-687. PubMed ID: 27903852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients.
    Htay H; Johnson DW; Wu SY; Oei EL; Foo MWY; Choo JCJ
    Perit Dial Int; 2017; 37(3):266-272. PubMed ID: 28183858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative analysis on the incidence of peritonitis and exit-site infection in CAPD and automated peritoneal dialysis.
    Rodríguez-Carmona A; Pérez Fontán M; García Falcón T; Fernández Rivera C; Valdés F
    Perit Dial Int; 1999; 19(3):253-8. PubMed ID: 10433162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Trio Trial - A Randomized Controlled Clinical Trial Evaluating the Effect of a Biocompatible Peritoneal Dialysis Solution on Residual Renal Function.
    Sikaneta T; Wu G; Abdolell M; Ng A; Mahdavi S; Svendrovski A; Tu T; Mercer T; Tong M; Oreopoulos D; Tam P
    Perit Dial Int; 2016 9-10; 36(5):526-32. PubMed ID: 27282852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site.
    Uttley L; Vardhan A; Mahajan S; Smart B; Hutchison A; Gokal R
    J Nephrol; 2004; 17(2):242-5. PubMed ID: 15293524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The microbial pattern of the catheter exit-site infection in peritoneal dialysis: A non-diphtheria Corynebacteria emergence?].
    Teixidó J; Arias N; Tarrats L; Romero R
    Nefrologia; 2007; 27(3):350-8. PubMed ID: 17725455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal catheter exit-site infections: predisposing factors, prevention and treatment.
    Thodis E; Passadakis P; Ossareh S; Panagoutsos S; Vargemezis V; Oreopoulos DG
    Int J Artif Organs; 2003 Aug; 26(8):698-714. PubMed ID: 14521167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute inflammation in peritoneal dialysis: experimental studies in rats. Characterization of regulatory mechanisms.
    Bazargani F
    Swed Dent J Suppl; 2005; (171):1-57, i. PubMed ID: 15847249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exit-Site Dressing and Infection in Peritoneal Dialysis: A Randomized Controlled Pilot Trial.
    Mushahar L; Mei LW; Yusuf WS; Sivathasan S; Kamaruddin N; Idzham NJ
    Perit Dial Int; 2016; 36(2):135-9. PubMed ID: 26374836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xanthomonas maltophilia infection in chronic peritoneal dialysis patients.
    Al-Hilali N; Nampoory MR; Johny KV; Chugh TD
    Scand J Urol Nephrol; 2000 Feb; 34(1):67-9. PubMed ID: 10757274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Exit-Site Gentamicin Prophylaxis and Gentamicin Resistance in a Peritoneal Dialysis Program.
    Chen SS; Sheth H; Piraino B; Bender F
    Perit Dial Int; 2016; 36(4):387-9. PubMed ID: 26634567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amuchina 10% solution, safe antiseptic for preventing infections of exit-site of Tenckhoff catheters, in the pediatric population of a dialysis program.
    Mendoza-Guevara L; Castro-Vazquez F; Aguilar-Kitsu A; Morales-Nava A; Rodriguez-Leyva F; Sanchez-Barbosa JL
    Contrib Nephrol; 2007; 154():139-144. PubMed ID: 17099309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.